SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,920,696 | -30.4% | 1,129,823 | -6.8% | 0.00% | -50.0% |
| Q2 2023 | $5,634,815 | +4.0% | 1,211,788 | +3.3% | 0.00% | 0.0% |
| Q1 2023 | $5,419,886 | +100417.2% | 1,173,199 | +75.7% | 0.00% | 0.0% |
| Q4 2022 | $5,392 | -99.8% | 667,543 | +46.2% | 0.00% | +100.0% |
| Q3 2022 | $2,534,000 | +33.7% | 456,583 | +25.6% | 0.00% | 0.0% |
| Q2 2022 | $1,895,000 | -48.4% | 363,645 | -18.6% | 0.00% | 0.0% |
| Q1 2022 | $3,674,000 | -31.6% | 446,955 | +23.9% | 0.00% | -50.0% |
| Q4 2021 | $5,369,000 | +13.2% | 360,765 | +43.7% | 0.00% | 0.0% |
| Q3 2021 | $4,742,000 | -24.6% | 251,081 | -25.8% | 0.00% | 0.0% |
| Q2 2021 | $6,287,000 | -23.6% | 338,187 | -6.6% | 0.00% | -33.3% |
| Q1 2021 | $8,229,000 | +284.5% | 362,177 | +267.5% | 0.00% | +200.0% |
| Q4 2020 | $2,140,000 | – | 98,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |